386 related articles for article (PubMed ID: 10692608)
21. Effect of Local Anesthetic Versus Botulinum Toxin-A Injections for Myofascial Pain Disorders: A Systematic Review and Meta-Analysis.
Ahmed S; Subramaniam S; Sidhu K; Khattab S; Singh D; Babineau J; Kumbhare DA
Clin J Pain; 2019 Apr; 35(4):353-367. PubMed ID: 30589660
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study.
Childers MK; Wilson DJ; Gnatz SM; Conway RR; Sherman AK
Am J Phys Med Rehabil; 2002 Oct; 81(10):751-9. PubMed ID: 12362115
[TBL] [Abstract][Full Text] [Related]
23. Botulinum Toxin type A injections for patients with painful hallux valgus: a double-blind, randomized controlled study.
Wu KP; Chen CK; Lin SC; Pei YC; Lin RH; Tsai WC; Fuk-Tan Tang S
Clin Neurol Neurosurg; 2015 Feb; 129 Suppl 1():S58-62. PubMed ID: 25683315
[TBL] [Abstract][Full Text] [Related]
24. Head and neck muscle spasm after radiotherapy: management with botulinum toxin A injection.
Van Daele DJ; Finnegan EM; Rodnitzky RL; Zhen W; McCulloch TM; Hoffman HT
Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):956-9. PubMed ID: 12162778
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
Wheeler AH; Goolkasian P; Gretz SS
Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
[TBL] [Abstract][Full Text] [Related]
26. Localized myofascial pain responds better than referring myofascial pain to botulinum toxin injections.
Abboud WA; Hassin-Baer S; Joachim M; Givol N; Yahalom R
Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1417-1423. PubMed ID: 28521968
[TBL] [Abstract][Full Text] [Related]
27. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
Thomas NJ; Aronovich S
J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
[TBL] [Abstract][Full Text] [Related]
28. [Use of botulinum toxin the the treatment of muscle pain].
Benecke R; Dressler D; Kunesch E; Probst T
Schmerz; 2003 Dec; 17(6):450-8. PubMed ID: 14648320
[TBL] [Abstract][Full Text] [Related]
29. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
Sherif H; Khalil M; Omar R
Can J Urol; 2017 Jun; 24(3):8838-8846. PubMed ID: 28646940
[TBL] [Abstract][Full Text] [Related]
30. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.
Adelowo A; Hacker MR; Shapiro A; Modest AM; Elkadry E
Female Pelvic Med Reconstr Surg; 2013; 19(5):288-92. PubMed ID: 23982578
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the Efficacy of Botulinum Toxin, Local Anesthesia, and Platelet-Rich Plasma Injections in Patients With Myofascial Trigger Points in the Masseter Muscle.
Yilmaz O; Sivrikaya EC; Taskesen F; Pirpir C; Ciftci S
J Oral Maxillofac Surg; 2021 Jan; 79(1):88.e1-88.e9. PubMed ID: 33045182
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
Nicol AL; Wu II; Ferrante FM
Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin in pain treatment.
Colhado OC; Boeing M; Ortega LB
Rev Bras Anestesiol; 2009; 59(3):366-81. PubMed ID: 19488551
[TBL] [Abstract][Full Text] [Related]
36. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
Laskin DM
Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
[TBL] [Abstract][Full Text] [Related]
37. Use of botulinum toxin type A in symptomatic accessory soleus muscle: first five cases.
Isner-Horobeti ME; Muff G; Lonsdorfer-Wolf E; Deffinis C; Masat J; Favret F; Dufour SP; Lecocq J
Scand J Med Sci Sports; 2016 Nov; 26(11):1373-1378. PubMed ID: 26627136
[TBL] [Abstract][Full Text] [Related]
38. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
39. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type A for refractory post-stroke shoulder pain.
Pedreira G; Cardoso E; Melo A
Arq Neuropsiquiatr; 2008 Jun; 66(2A):213-5. PubMed ID: 18545785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
